Low lung function, sudden cardiac death and non-fatal coronary events in the general population

Suneela Zaigham1, Karl-Fredrik Eriksson2, Per Wollmer3,4

  • 1Department of Clinical Sciences, Lund University, Malmö, Sweden suneela.zaigham@med.lu.se.

Insights

Reduced lung function, specifically lower forced expiratory volume in 1 second (FEV1), strongly predicts sudden cardiac death (SCD) risk more than non-fatal cardiac events (CE). Spirometry can help assess cardiovascular risk.

Area of Science:

  • Cardiology
  • Pulmonology
  • Epidemiology

Background:

  • Sudden cardiac death (SCD) is a leading cause of mortality following acute coronary events (CE).
  • Poor lung function is a known predictor of cardiac events, but its differential impact on SCD versus non-fatal CE is unclear.
  • This population-based study investigates the relationship between lung function and the risk of future SCD and non-fatal CE.

Purpose of the Study:

  • To determine if lung function impairment patterns differ in predicting sudden cardiac death (SCD) compared to non-fatal cardiac events (CE).
  • To examine the association between spirometry measures and future SCD and non-fatal CE incidence.

Main Methods:

  • Prospective cohort study of 28,584 middle-aged subjects from the Malmö Preventive Project.
  • Baseline spirometry (FEV1, FVC, FEV1/FVC) was assessed in individuals with no prior CE history.
  • Cox regression models, using a modified Lunn McNeil competing risk method, analyzed the incidence of SCD and non-fatal CE.

Main Results:

  • A 1-second reduction in forced expiratory volume (FEV1) showed a stronger association with SCD (HR 1.23) than non-fatal CE (HR 1.08), even after full adjustment (p=0.002).
  • Similar associations were observed for forced vital capacity (FVC), but not the FEV1/FVC ratio.
  • These findings persisted in lifelong never-smokers, indicating a robust link between lung function and SCD risk.

Conclusions:

  • Reduced FEV1 is significantly associated with both SCD and non-fatal CE, but more strongly predicts future SCD.
  • Spirometry measurements in earlier life may aid in stratifying individuals at risk for SCD.
  • Spirometry is a valuable tool for a comprehensive assessment of overall cardiovascular risk.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
78
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
504
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
90
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
401
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
47
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
84